Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$436M |
| 2 |
Philip Morris
PM
|
+$367M |
| 3 |
Altria Group
MO
|
+$345M |
| 4 |
Coca-Cola
KO
|
+$284M |
| 5 |
Microsoft
MSFT
|
+$271M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NYX
NYSE EURONEXT INC
NYX
|
+$186M |
| 2 |
Baxter International
BAX
|
+$154M |
| 3 |
Amgen
AMGN
|
+$139M |
| 4 |
Magna International
MGA
|
+$80.7M |
| 5 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$62.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.16% |
| 2 | Industrials | 11.96% |
| 3 | Financials | 10.82% |
| 4 | Consumer Discretionary | 10.38% |
| 5 | Technology | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Microsoft
MSFT
$3.71T
| $876M | 2.72% |
23,402,107
+7,472,309
| +47% | +$271M |
|
|
2
Bristol-Myers Squibb
BMY
$131B
| $851M | 2.64% |
16,019,500
+8,550,000
| +114% | +$436M |
|
3
Gilead Sciences
GILD
$162B
| $758M | 2.35% |
10,087,700
| – | – |
|
4
DuPont de Nemours
DD
$19.5B
| $722M | 2.24% |
6,420,983
+2,457,626
| +62% | +$252M |
|
5
Texas Instruments
TXN
$254B
| $689M | 2.14% |
15,691,559
+2,123,300
| +16% | +$88.9M |
|
6
Home Depot
HD
$349B
| $607M | 1.89% |
7,376,702
-43,000
| -0.6% | -$3.35M |
|
7
Oracle
ORCL
$413B
| $550M | 1.71% |
14,384,000
| – | – |
|
8
AbbVie
ABBV
$431B
| $548M | 1.7% |
10,372,275
+4,245,275
| +69% | +$209M |
|
9
Merck
MRK
$317B
| $541M | 1.68% |
11,329,488
+3,277,295
| +41% | +$150M |
|
|
10
Coca-Cola
KO
$374B
| $527M | 1.63% |
12,749,200
+7,190,500
| +129% | +$284M |
|
11
Pfizer
PFE
$149B
| $505M | 1.57% |
17,363,544
+7,689,035
| +79% | +$224M |
|
12
Chevron
CVX
$371B
| $501M | 1.56% |
4,010,850
+1,558,150
| +64% | +$188M |
|
13
RTX Corp
RTX
$301B
| $424M | 1.32% |
5,918,866
+862,827
| +17% | +$58.8M |
|
14
ConocoPhillips
COP
$140B
| $417M | 1.3% |
5,906,260
+1,927,900
| +48% | +$138M |
|
15
Amazon
AMZN
$2.94T
| $411M | 1.27% |
20,596,000
| – | – |
|
16
Verizon
VZ
$195B
| $409M | 1.27% |
8,325,997
+3,773,300
| +83% | +$186M |
|
17
JPMorgan Chase
JPM
$947B
| $386M | 1.2% |
6,607,000
+2,582,000
| +64% | +$141M |
|
18
Carnival Corporation Ltd
CCL
$39.4B
| $384M | 1.19% |
9,564,100
+702,500
| +8% | +$24.8M |
|
|
19
Philip Morris
PM
$293B
| $366M | 1.14% |
+4,200,000
| New | +$367M |
|
20
Apple
AAPL
$4.56T
| $363M | 1.13% |
18,104,800
+4,076,800
| +29% | +$77M |
|
|
21
Altria Group
MO
$113B
| $359M | 1.11% |
+9,348,000
| New | +$345M |
|
22
Arthur J. Gallagher & Co
AJG
$64.5B
| $342M | 1.06% |
7,277,537
+3,394,089
| +87% | +$158M |
|
|
23
Amgen
AMGN
$219B
| $341M | 1.06% |
2,985,048
-1,224,700
| -29% | -$139M |
|
24
Newell Brands
NWL
$2.56B
| $330M | 1.02% |
10,182,100
+3,402,100
| +50% | +$101M |
|
25
Scotiabank
BNS
$108B
| $307M | 0.95% |
5,285,119
+1,453,841
| +38% | +$81.5M |
|
Similar funds
Capital International Investors's Q4 2013 Portfolio in Review
As of Q4 2013, Capital International Investors held 214 positions worth $32.2B, up 38% from $23.4B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Capital International Investors deployed $6.3B of net new capital in Q4 2013, opening 17 new positions and adding to 68 existing holdings. Its largest new stake was Philip Morris: 4,200,000 shares worth $366M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Amgen, an estimated $139M trimmed.
- Capital International Investors's largest Q4 2013 buy was Philip Morris: 4,200,000 shares worth $366M.
- Capital International Investors added most to Bristol-Myers Squibb in Q4 2013, an estimated $436M increase.
- Capital International Investors's biggest Q4 2013 reduction was Amgen, cutting an estimated $139M.
- Capital International Investors fully exited NYSE EURONEXT INC in Q4 2013, selling an estimated $186M.
- Capital International Investors's ten largest holdings make up 21% of its $32.2B portfolio in Q4 2013.
- Capital International Investors opened 17 new positions and closed 11 in Q4 2013.
- Capital International Investors's portfolio value rose 38% quarter-over-quarter to $32.2B.
Based on Capital International Investors's 13F filing for Q4 2013, filed 14 Feb 2014.